Merck planning to mothball Sivextro (a la Invanz) by slashing sales force??

Could Merck be so EVIL as to do such a thing? Can someone please confirm (or preferably deny) this for me please? It just seems like the most sadistic way possible to do this. Grow some balls guys!!

 

Not even sure wtf you are asking....English please.

 

yes I heard that as well

 

Merck side here. Not hearing that. Invanz goes generic end of 2015. At a recent meeting, it was stated Sivextro was under promoted at launch and would make sense to add.

 

Sales aren't going anywhere fast, unfortunately. Merck will have to pay me one dollar for every Trius CVR I own (and I own a bunch) if they achieve 2016 sales of Sivextro of 125 million and then another dollar prorated over the next 10 million in sales. It doesn't take much to see they can save bunch of money by dragging their feet so that sales don't achieve those milestones until 2017.

When Trius sold out to Cubist a couple of years ago, I told myself that watching how these CVRs do will be very educational.

 

Class action lawsuit to make them open their books perhaps?